Important article on triple negative breast cancer by Dr Fergus Keane and Dr Cathy Kelly just published in The Medical Independent.
From all of us at Head Office and our colleagues in our 14 research units around the country, we wish you a merry and peaceful Christmas and New Year.
50 Patients in Cork, Waterford and Dublin to get access to drug not yet approved in Ireland for early stage breast cancer
The Irish arm of a global cancer trial which will involve 4,600 patients in 500 hospitals around the world has been opened in Ireland by Cancer Trials Ireland and is looking for 50 Irish patients to take part.
Dr Janice Walsh, Principal Investigator on the Paloma-2 trials discusses the results on RTE (13th December) HERE
An international cancer trial, in which Cancer Trials Ireland has had a lead role, has confirmed a treatment that can significantly reduce the risk of the cancer progressing in women with advanced breast cancer.
As of today, the European Medicines Agency (EMA) gives open access to clinical reports for new medicines for human use authorised in the European Union (EU).
Congratulations to Irish life-sciences start-up Genomics Medicine Irelandwhich today (26th October) announced it has raised $40 million in investment.
Sat, 12 Nov & Sun, 13 Nov 2016
This conference is for women who are from families carrying BRCA1 or BRCA2 mutations.
Some of the 2015 Highlights: 14 hospital based cancer trials research units around the country were working on 154 trials involving 6312 patients; 66 were recruiting patients and 88 were in the follow up stage. There were also 16 paediatric cancer trials.